Medical Care
Global Biomacromolecule CDMO Market Research Report 2025
- May 12, 25
- ID: 235820
- Pages: 97
- Figures: 95
- Views: 9
The global market for Biomacromolecule CDMO was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
The macromolecule CDMO industry refers to drugs that rely on cell biosynthesis, usually with a molecular weight greater than 1,000. Macromolecule CDMO mainly focuses on biopharmaceuticals, and the intermediates are relatively unified, mainly including some raw materials, protein and antibody preparation, stable cell lines and process development, and the production and research and development of biological preparations.
North American market for Biomacromolecule CDMO is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Biomacromolecule CDMO is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The global market for Biomacromolecule CDMO in Drug Development is estimated to increase from $ million in 2024 to $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global companies of Biomacromolecule CDMO include Lonza, Wuxi Biologics (Cayman) Inc., Catalent, Thermo Fisher Scientific, Samsung Biologics, Rentschler Biopharma, Baxter Biopharma Solutions, Merck BioReliance, Cytovance Biologics, AGC Biologics, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Biomacromolecule CDMO, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Biomacromolecule CDMO.
The Biomacromolecule CDMO market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Biomacromolecule CDMO market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Biomacromolecule CDMO companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Lonza
Wuxi Biologics (Cayman) Inc.
Catalent
Thermo Fisher Scientific
Samsung Biologics
Rentschler Biopharma
Baxter Biopharma Solutions
Merck BioReliance
Cytovance Biologics
AGC Biologics
Abzena
Emergent BioSolutions
ProBioGen
Goodwin Biotechnology
KBI Biopharma
Asymchem Laboratories (Tianjin) Co., Ltd.
Shanghai Chempartner Lifescience Co., Ltd.
Zhejiang Jian Xin Yuan Li Pharmaceuticals Co., Ltd.
Genscript Biotech
Beijing Joinn Biologics Co., Ltd.
Segment by Type
Biologics CDMO
Viral Vaccine Production CDMO
Analyze and Test CDMOs
Others
Segment by Application
Drug Development
Vaccine Production
Technology Transfer
Others
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Biomacromolecule CDMO company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
The macromolecule CDMO industry refers to drugs that rely on cell biosynthesis, usually with a molecular weight greater than 1,000. Macromolecule CDMO mainly focuses on biopharmaceuticals, and the intermediates are relatively unified, mainly including some raw materials, protein and antibody preparation, stable cell lines and process development, and the production and research and development of biological preparations.
North American market for Biomacromolecule CDMO is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Biomacromolecule CDMO is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The global market for Biomacromolecule CDMO in Drug Development is estimated to increase from $ million in 2024 to $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global companies of Biomacromolecule CDMO include Lonza, Wuxi Biologics (Cayman) Inc., Catalent, Thermo Fisher Scientific, Samsung Biologics, Rentschler Biopharma, Baxter Biopharma Solutions, Merck BioReliance, Cytovance Biologics, AGC Biologics, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Biomacromolecule CDMO, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Biomacromolecule CDMO.
The Biomacromolecule CDMO market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Biomacromolecule CDMO market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Biomacromolecule CDMO companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Lonza
Wuxi Biologics (Cayman) Inc.
Catalent
Thermo Fisher Scientific
Samsung Biologics
Rentschler Biopharma
Baxter Biopharma Solutions
Merck BioReliance
Cytovance Biologics
AGC Biologics
Abzena
Emergent BioSolutions
ProBioGen
Goodwin Biotechnology
KBI Biopharma
Asymchem Laboratories (Tianjin) Co., Ltd.
Shanghai Chempartner Lifescience Co., Ltd.
Zhejiang Jian Xin Yuan Li Pharmaceuticals Co., Ltd.
Genscript Biotech
Beijing Joinn Biologics Co., Ltd.
Segment by Type
Biologics CDMO
Viral Vaccine Production CDMO
Analyze and Test CDMOs
Others
Segment by Application
Drug Development
Vaccine Production
Technology Transfer
Others
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Biomacromolecule CDMO company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Biomacromolecule CDMO Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Biologics CDMO
1.2.3 Viral Vaccine Production CDMO
1.2.4 Analyze and Test CDMOs
1.2.5 Others
1.3 Market by Application
1.3.1 Global Biomacromolecule CDMO Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Drug Development
1.3.3 Vaccine Production
1.3.4 Technology Transfer
1.3.5 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Biomacromolecule CDMO Market Perspective (2020-2031)
2.2 Global Biomacromolecule CDMO Growth Trends by Region
2.2.1 Global Biomacromolecule CDMO Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Biomacromolecule CDMO Historic Market Size by Region (2020-2025)
2.2.3 Biomacromolecule CDMO Forecasted Market Size by Region (2026-2031)
2.3 Biomacromolecule CDMO Market Dynamics
2.3.1 Biomacromolecule CDMO Industry Trends
2.3.2 Biomacromolecule CDMO Market Drivers
2.3.3 Biomacromolecule CDMO Market Challenges
2.3.4 Biomacromolecule CDMO Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Biomacromolecule CDMO Players by Revenue
3.1.1 Global Top Biomacromolecule CDMO Players by Revenue (2020-2025)
3.1.2 Global Biomacromolecule CDMO Revenue Market Share by Players (2020-2025)
3.2 Global Biomacromolecule CDMO Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Biomacromolecule CDMO Revenue
3.4 Global Biomacromolecule CDMO Market Concentration Ratio
3.4.1 Global Biomacromolecule CDMO Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Biomacromolecule CDMO Revenue in 2024
3.5 Global Key Players of Biomacromolecule CDMO Head office and Area Served
3.6 Global Key Players of Biomacromolecule CDMO, Product and Application
3.7 Global Key Players of Biomacromolecule CDMO, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Biomacromolecule CDMO Breakdown Data by Type
4.1 Global Biomacromolecule CDMO Historic Market Size by Type (2020-2025)
4.2 Global Biomacromolecule CDMO Forecasted Market Size by Type (2026-2031)
5 Biomacromolecule CDMO Breakdown Data by Application
5.1 Global Biomacromolecule CDMO Historic Market Size by Application (2020-2025)
5.2 Global Biomacromolecule CDMO Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Biomacromolecule CDMO Market Size (2020-2031)
6.2 North America Biomacromolecule CDMO Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Biomacromolecule CDMO Market Size by Country (2020-2025)
6.4 North America Biomacromolecule CDMO Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Biomacromolecule CDMO Market Size (2020-2031)
7.2 Europe Biomacromolecule CDMO Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Biomacromolecule CDMO Market Size by Country (2020-2025)
7.4 Europe Biomacromolecule CDMO Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Biomacromolecule CDMO Market Size (2020-2031)
8.2 Asia-Pacific Biomacromolecule CDMO Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Biomacromolecule CDMO Market Size by Region (2020-2025)
8.4 Asia-Pacific Biomacromolecule CDMO Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Biomacromolecule CDMO Market Size (2020-2031)
9.2 Latin America Biomacromolecule CDMO Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Biomacromolecule CDMO Market Size by Country (2020-2025)
9.4 Latin America Biomacromolecule CDMO Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Biomacromolecule CDMO Market Size (2020-2031)
10.2 Middle East & Africa Biomacromolecule CDMO Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Biomacromolecule CDMO Market Size by Country (2020-2025)
10.4 Middle East & Africa Biomacromolecule CDMO Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Lonza
11.1.1 Lonza Company Details
11.1.2 Lonza Business Overview
11.1.3 Lonza Biomacromolecule CDMO Introduction
11.1.4 Lonza Revenue in Biomacromolecule CDMO Business (2020-2025)
11.1.5 Lonza Recent Development
11.2 Wuxi Biologics (Cayman) Inc.
11.2.1 Wuxi Biologics (Cayman) Inc. Company Details
11.2.2 Wuxi Biologics (Cayman) Inc. Business Overview
11.2.3 Wuxi Biologics (Cayman) Inc. Biomacromolecule CDMO Introduction
11.2.4 Wuxi Biologics (Cayman) Inc. Revenue in Biomacromolecule CDMO Business (2020-2025)
11.2.5 Wuxi Biologics (Cayman) Inc. Recent Development
11.3 Catalent
11.3.1 Catalent Company Details
11.3.2 Catalent Business Overview
11.3.3 Catalent Biomacromolecule CDMO Introduction
11.3.4 Catalent Revenue in Biomacromolecule CDMO Business (2020-2025)
11.3.5 Catalent Recent Development
11.4 Thermo Fisher Scientific
11.4.1 Thermo Fisher Scientific Company Details
11.4.2 Thermo Fisher Scientific Business Overview
11.4.3 Thermo Fisher Scientific Biomacromolecule CDMO Introduction
11.4.4 Thermo Fisher Scientific Revenue in Biomacromolecule CDMO Business (2020-2025)
11.4.5 Thermo Fisher Scientific Recent Development
11.5 Samsung Biologics
11.5.1 Samsung Biologics Company Details
11.5.2 Samsung Biologics Business Overview
11.5.3 Samsung Biologics Biomacromolecule CDMO Introduction
11.5.4 Samsung Biologics Revenue in Biomacromolecule CDMO Business (2020-2025)
11.5.5 Samsung Biologics Recent Development
11.6 Rentschler Biopharma
11.6.1 Rentschler Biopharma Company Details
11.6.2 Rentschler Biopharma Business Overview
11.6.3 Rentschler Biopharma Biomacromolecule CDMO Introduction
11.6.4 Rentschler Biopharma Revenue in Biomacromolecule CDMO Business (2020-2025)
11.6.5 Rentschler Biopharma Recent Development
11.7 Baxter Biopharma Solutions
11.7.1 Baxter Biopharma Solutions Company Details
11.7.2 Baxter Biopharma Solutions Business Overview
11.7.3 Baxter Biopharma Solutions Biomacromolecule CDMO Introduction
11.7.4 Baxter Biopharma Solutions Revenue in Biomacromolecule CDMO Business (2020-2025)
11.7.5 Baxter Biopharma Solutions Recent Development
11.8 Merck BioReliance
11.8.1 Merck BioReliance Company Details
11.8.2 Merck BioReliance Business Overview
11.8.3 Merck BioReliance Biomacromolecule CDMO Introduction
11.8.4 Merck BioReliance Revenue in Biomacromolecule CDMO Business (2020-2025)
11.8.5 Merck BioReliance Recent Development
11.9 Cytovance Biologics
11.9.1 Cytovance Biologics Company Details
11.9.2 Cytovance Biologics Business Overview
11.9.3 Cytovance Biologics Biomacromolecule CDMO Introduction
11.9.4 Cytovance Biologics Revenue in Biomacromolecule CDMO Business (2020-2025)
11.9.5 Cytovance Biologics Recent Development
11.10 AGC Biologics
11.10.1 AGC Biologics Company Details
11.10.2 AGC Biologics Business Overview
11.10.3 AGC Biologics Biomacromolecule CDMO Introduction
11.10.4 AGC Biologics Revenue in Biomacromolecule CDMO Business (2020-2025)
11.10.5 AGC Biologics Recent Development
11.11 Abzena
11.11.1 Abzena Company Details
11.11.2 Abzena Business Overview
11.11.3 Abzena Biomacromolecule CDMO Introduction
11.11.4 Abzena Revenue in Biomacromolecule CDMO Business (2020-2025)
11.11.5 Abzena Recent Development
11.12 Emergent BioSolutions
11.12.1 Emergent BioSolutions Company Details
11.12.2 Emergent BioSolutions Business Overview
11.12.3 Emergent BioSolutions Biomacromolecule CDMO Introduction
11.12.4 Emergent BioSolutions Revenue in Biomacromolecule CDMO Business (2020-2025)
11.12.5 Emergent BioSolutions Recent Development
11.13 ProBioGen
11.13.1 ProBioGen Company Details
11.13.2 ProBioGen Business Overview
11.13.3 ProBioGen Biomacromolecule CDMO Introduction
11.13.4 ProBioGen Revenue in Biomacromolecule CDMO Business (2020-2025)
11.13.5 ProBioGen Recent Development
11.14 Goodwin Biotechnology
11.14.1 Goodwin Biotechnology Company Details
11.14.2 Goodwin Biotechnology Business Overview
11.14.3 Goodwin Biotechnology Biomacromolecule CDMO Introduction
11.14.4 Goodwin Biotechnology Revenue in Biomacromolecule CDMO Business (2020-2025)
11.14.5 Goodwin Biotechnology Recent Development
11.15 KBI Biopharma
11.15.1 KBI Biopharma Company Details
11.15.2 KBI Biopharma Business Overview
11.15.3 KBI Biopharma Biomacromolecule CDMO Introduction
11.15.4 KBI Biopharma Revenue in Biomacromolecule CDMO Business (2020-2025)
11.15.5 KBI Biopharma Recent Development
11.16 Asymchem Laboratories (Tianjin) Co., Ltd.
11.16.1 Asymchem Laboratories (Tianjin) Co., Ltd. Company Details
11.16.2 Asymchem Laboratories (Tianjin) Co., Ltd. Business Overview
11.16.3 Asymchem Laboratories (Tianjin) Co., Ltd. Biomacromolecule CDMO Introduction
11.16.4 Asymchem Laboratories (Tianjin) Co., Ltd. Revenue in Biomacromolecule CDMO Business (2020-2025)
11.16.5 Asymchem Laboratories (Tianjin) Co., Ltd. Recent Development
11.17 Shanghai Chempartner Lifescience Co., Ltd.
11.17.1 Shanghai Chempartner Lifescience Co., Ltd. Company Details
11.17.2 Shanghai Chempartner Lifescience Co., Ltd. Business Overview
11.17.3 Shanghai Chempartner Lifescience Co., Ltd. Biomacromolecule CDMO Introduction
11.17.4 Shanghai Chempartner Lifescience Co., Ltd. Revenue in Biomacromolecule CDMO Business (2020-2025)
11.17.5 Shanghai Chempartner Lifescience Co., Ltd. Recent Development
11.18 Zhejiang Jian Xin Yuan Li Pharmaceuticals Co., Ltd.
11.18.1 Zhejiang Jian Xin Yuan Li Pharmaceuticals Co., Ltd. Company Details
11.18.2 Zhejiang Jian Xin Yuan Li Pharmaceuticals Co., Ltd. Business Overview
11.18.3 Zhejiang Jian Xin Yuan Li Pharmaceuticals Co., Ltd. Biomacromolecule CDMO Introduction
11.18.4 Zhejiang Jian Xin Yuan Li Pharmaceuticals Co., Ltd. Revenue in Biomacromolecule CDMO Business (2020-2025)
11.18.5 Zhejiang Jian Xin Yuan Li Pharmaceuticals Co., Ltd. Recent Development
11.19 Genscript Biotech
11.19.1 Genscript Biotech Company Details
11.19.2 Genscript Biotech Business Overview
11.19.3 Genscript Biotech Biomacromolecule CDMO Introduction
11.19.4 Genscript Biotech Revenue in Biomacromolecule CDMO Business (2020-2025)
11.19.5 Genscript Biotech Recent Development
11.20 Beijing Joinn Biologics Co., Ltd.
11.20.1 Beijing Joinn Biologics Co., Ltd. Company Details
11.20.2 Beijing Joinn Biologics Co., Ltd. Business Overview
11.20.3 Beijing Joinn Biologics Co., Ltd. Biomacromolecule CDMO Introduction
11.20.4 Beijing Joinn Biologics Co., Ltd. Revenue in Biomacromolecule CDMO Business (2020-2025)
11.20.5 Beijing Joinn Biologics Co., Ltd. Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Biomacromolecule CDMO Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Biologics CDMO
1.2.3 Viral Vaccine Production CDMO
1.2.4 Analyze and Test CDMOs
1.2.5 Others
1.3 Market by Application
1.3.1 Global Biomacromolecule CDMO Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Drug Development
1.3.3 Vaccine Production
1.3.4 Technology Transfer
1.3.5 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Biomacromolecule CDMO Market Perspective (2020-2031)
2.2 Global Biomacromolecule CDMO Growth Trends by Region
2.2.1 Global Biomacromolecule CDMO Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Biomacromolecule CDMO Historic Market Size by Region (2020-2025)
2.2.3 Biomacromolecule CDMO Forecasted Market Size by Region (2026-2031)
2.3 Biomacromolecule CDMO Market Dynamics
2.3.1 Biomacromolecule CDMO Industry Trends
2.3.2 Biomacromolecule CDMO Market Drivers
2.3.3 Biomacromolecule CDMO Market Challenges
2.3.4 Biomacromolecule CDMO Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Biomacromolecule CDMO Players by Revenue
3.1.1 Global Top Biomacromolecule CDMO Players by Revenue (2020-2025)
3.1.2 Global Biomacromolecule CDMO Revenue Market Share by Players (2020-2025)
3.2 Global Biomacromolecule CDMO Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Biomacromolecule CDMO Revenue
3.4 Global Biomacromolecule CDMO Market Concentration Ratio
3.4.1 Global Biomacromolecule CDMO Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Biomacromolecule CDMO Revenue in 2024
3.5 Global Key Players of Biomacromolecule CDMO Head office and Area Served
3.6 Global Key Players of Biomacromolecule CDMO, Product and Application
3.7 Global Key Players of Biomacromolecule CDMO, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Biomacromolecule CDMO Breakdown Data by Type
4.1 Global Biomacromolecule CDMO Historic Market Size by Type (2020-2025)
4.2 Global Biomacromolecule CDMO Forecasted Market Size by Type (2026-2031)
5 Biomacromolecule CDMO Breakdown Data by Application
5.1 Global Biomacromolecule CDMO Historic Market Size by Application (2020-2025)
5.2 Global Biomacromolecule CDMO Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Biomacromolecule CDMO Market Size (2020-2031)
6.2 North America Biomacromolecule CDMO Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Biomacromolecule CDMO Market Size by Country (2020-2025)
6.4 North America Biomacromolecule CDMO Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Biomacromolecule CDMO Market Size (2020-2031)
7.2 Europe Biomacromolecule CDMO Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Biomacromolecule CDMO Market Size by Country (2020-2025)
7.4 Europe Biomacromolecule CDMO Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Biomacromolecule CDMO Market Size (2020-2031)
8.2 Asia-Pacific Biomacromolecule CDMO Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Biomacromolecule CDMO Market Size by Region (2020-2025)
8.4 Asia-Pacific Biomacromolecule CDMO Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Biomacromolecule CDMO Market Size (2020-2031)
9.2 Latin America Biomacromolecule CDMO Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Biomacromolecule CDMO Market Size by Country (2020-2025)
9.4 Latin America Biomacromolecule CDMO Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Biomacromolecule CDMO Market Size (2020-2031)
10.2 Middle East & Africa Biomacromolecule CDMO Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Biomacromolecule CDMO Market Size by Country (2020-2025)
10.4 Middle East & Africa Biomacromolecule CDMO Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Lonza
11.1.1 Lonza Company Details
11.1.2 Lonza Business Overview
11.1.3 Lonza Biomacromolecule CDMO Introduction
11.1.4 Lonza Revenue in Biomacromolecule CDMO Business (2020-2025)
11.1.5 Lonza Recent Development
11.2 Wuxi Biologics (Cayman) Inc.
11.2.1 Wuxi Biologics (Cayman) Inc. Company Details
11.2.2 Wuxi Biologics (Cayman) Inc. Business Overview
11.2.3 Wuxi Biologics (Cayman) Inc. Biomacromolecule CDMO Introduction
11.2.4 Wuxi Biologics (Cayman) Inc. Revenue in Biomacromolecule CDMO Business (2020-2025)
11.2.5 Wuxi Biologics (Cayman) Inc. Recent Development
11.3 Catalent
11.3.1 Catalent Company Details
11.3.2 Catalent Business Overview
11.3.3 Catalent Biomacromolecule CDMO Introduction
11.3.4 Catalent Revenue in Biomacromolecule CDMO Business (2020-2025)
11.3.5 Catalent Recent Development
11.4 Thermo Fisher Scientific
11.4.1 Thermo Fisher Scientific Company Details
11.4.2 Thermo Fisher Scientific Business Overview
11.4.3 Thermo Fisher Scientific Biomacromolecule CDMO Introduction
11.4.4 Thermo Fisher Scientific Revenue in Biomacromolecule CDMO Business (2020-2025)
11.4.5 Thermo Fisher Scientific Recent Development
11.5 Samsung Biologics
11.5.1 Samsung Biologics Company Details
11.5.2 Samsung Biologics Business Overview
11.5.3 Samsung Biologics Biomacromolecule CDMO Introduction
11.5.4 Samsung Biologics Revenue in Biomacromolecule CDMO Business (2020-2025)
11.5.5 Samsung Biologics Recent Development
11.6 Rentschler Biopharma
11.6.1 Rentschler Biopharma Company Details
11.6.2 Rentschler Biopharma Business Overview
11.6.3 Rentschler Biopharma Biomacromolecule CDMO Introduction
11.6.4 Rentschler Biopharma Revenue in Biomacromolecule CDMO Business (2020-2025)
11.6.5 Rentschler Biopharma Recent Development
11.7 Baxter Biopharma Solutions
11.7.1 Baxter Biopharma Solutions Company Details
11.7.2 Baxter Biopharma Solutions Business Overview
11.7.3 Baxter Biopharma Solutions Biomacromolecule CDMO Introduction
11.7.4 Baxter Biopharma Solutions Revenue in Biomacromolecule CDMO Business (2020-2025)
11.7.5 Baxter Biopharma Solutions Recent Development
11.8 Merck BioReliance
11.8.1 Merck BioReliance Company Details
11.8.2 Merck BioReliance Business Overview
11.8.3 Merck BioReliance Biomacromolecule CDMO Introduction
11.8.4 Merck BioReliance Revenue in Biomacromolecule CDMO Business (2020-2025)
11.8.5 Merck BioReliance Recent Development
11.9 Cytovance Biologics
11.9.1 Cytovance Biologics Company Details
11.9.2 Cytovance Biologics Business Overview
11.9.3 Cytovance Biologics Biomacromolecule CDMO Introduction
11.9.4 Cytovance Biologics Revenue in Biomacromolecule CDMO Business (2020-2025)
11.9.5 Cytovance Biologics Recent Development
11.10 AGC Biologics
11.10.1 AGC Biologics Company Details
11.10.2 AGC Biologics Business Overview
11.10.3 AGC Biologics Biomacromolecule CDMO Introduction
11.10.4 AGC Biologics Revenue in Biomacromolecule CDMO Business (2020-2025)
11.10.5 AGC Biologics Recent Development
11.11 Abzena
11.11.1 Abzena Company Details
11.11.2 Abzena Business Overview
11.11.3 Abzena Biomacromolecule CDMO Introduction
11.11.4 Abzena Revenue in Biomacromolecule CDMO Business (2020-2025)
11.11.5 Abzena Recent Development
11.12 Emergent BioSolutions
11.12.1 Emergent BioSolutions Company Details
11.12.2 Emergent BioSolutions Business Overview
11.12.3 Emergent BioSolutions Biomacromolecule CDMO Introduction
11.12.4 Emergent BioSolutions Revenue in Biomacromolecule CDMO Business (2020-2025)
11.12.5 Emergent BioSolutions Recent Development
11.13 ProBioGen
11.13.1 ProBioGen Company Details
11.13.2 ProBioGen Business Overview
11.13.3 ProBioGen Biomacromolecule CDMO Introduction
11.13.4 ProBioGen Revenue in Biomacromolecule CDMO Business (2020-2025)
11.13.5 ProBioGen Recent Development
11.14 Goodwin Biotechnology
11.14.1 Goodwin Biotechnology Company Details
11.14.2 Goodwin Biotechnology Business Overview
11.14.3 Goodwin Biotechnology Biomacromolecule CDMO Introduction
11.14.4 Goodwin Biotechnology Revenue in Biomacromolecule CDMO Business (2020-2025)
11.14.5 Goodwin Biotechnology Recent Development
11.15 KBI Biopharma
11.15.1 KBI Biopharma Company Details
11.15.2 KBI Biopharma Business Overview
11.15.3 KBI Biopharma Biomacromolecule CDMO Introduction
11.15.4 KBI Biopharma Revenue in Biomacromolecule CDMO Business (2020-2025)
11.15.5 KBI Biopharma Recent Development
11.16 Asymchem Laboratories (Tianjin) Co., Ltd.
11.16.1 Asymchem Laboratories (Tianjin) Co., Ltd. Company Details
11.16.2 Asymchem Laboratories (Tianjin) Co., Ltd. Business Overview
11.16.3 Asymchem Laboratories (Tianjin) Co., Ltd. Biomacromolecule CDMO Introduction
11.16.4 Asymchem Laboratories (Tianjin) Co., Ltd. Revenue in Biomacromolecule CDMO Business (2020-2025)
11.16.5 Asymchem Laboratories (Tianjin) Co., Ltd. Recent Development
11.17 Shanghai Chempartner Lifescience Co., Ltd.
11.17.1 Shanghai Chempartner Lifescience Co., Ltd. Company Details
11.17.2 Shanghai Chempartner Lifescience Co., Ltd. Business Overview
11.17.3 Shanghai Chempartner Lifescience Co., Ltd. Biomacromolecule CDMO Introduction
11.17.4 Shanghai Chempartner Lifescience Co., Ltd. Revenue in Biomacromolecule CDMO Business (2020-2025)
11.17.5 Shanghai Chempartner Lifescience Co., Ltd. Recent Development
11.18 Zhejiang Jian Xin Yuan Li Pharmaceuticals Co., Ltd.
11.18.1 Zhejiang Jian Xin Yuan Li Pharmaceuticals Co., Ltd. Company Details
11.18.2 Zhejiang Jian Xin Yuan Li Pharmaceuticals Co., Ltd. Business Overview
11.18.3 Zhejiang Jian Xin Yuan Li Pharmaceuticals Co., Ltd. Biomacromolecule CDMO Introduction
11.18.4 Zhejiang Jian Xin Yuan Li Pharmaceuticals Co., Ltd. Revenue in Biomacromolecule CDMO Business (2020-2025)
11.18.5 Zhejiang Jian Xin Yuan Li Pharmaceuticals Co., Ltd. Recent Development
11.19 Genscript Biotech
11.19.1 Genscript Biotech Company Details
11.19.2 Genscript Biotech Business Overview
11.19.3 Genscript Biotech Biomacromolecule CDMO Introduction
11.19.4 Genscript Biotech Revenue in Biomacromolecule CDMO Business (2020-2025)
11.19.5 Genscript Biotech Recent Development
11.20 Beijing Joinn Biologics Co., Ltd.
11.20.1 Beijing Joinn Biologics Co., Ltd. Company Details
11.20.2 Beijing Joinn Biologics Co., Ltd. Business Overview
11.20.3 Beijing Joinn Biologics Co., Ltd. Biomacromolecule CDMO Introduction
11.20.4 Beijing Joinn Biologics Co., Ltd. Revenue in Biomacromolecule CDMO Business (2020-2025)
11.20.5 Beijing Joinn Biologics Co., Ltd. Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global Biomacromolecule CDMO Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Biologics CDMO
Table 3. Key Players of Viral Vaccine Production CDMO
Table 4. Key Players of Analyze and Test CDMOs
Table 5. Key Players of Others
Table 6. Global Biomacromolecule CDMO Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 7. Global Biomacromolecule CDMO Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 8. Global Biomacromolecule CDMO Market Size by Region (2020-2025) & (US$ Million)
Table 9. Global Biomacromolecule CDMO Market Share by Region (2020-2025)
Table 10. Global Biomacromolecule CDMO Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 11. Global Biomacromolecule CDMO Market Share by Region (2026-2031)
Table 12. Biomacromolecule CDMO Market Trends
Table 13. Biomacromolecule CDMO Market Drivers
Table 14. Biomacromolecule CDMO Market Challenges
Table 15. Biomacromolecule CDMO Market Restraints
Table 16. Global Biomacromolecule CDMO Revenue by Players (2020-2025) & (US$ Million)
Table 17. Global Biomacromolecule CDMO Market Share by Players (2020-2025)
Table 18. Global Top Biomacromolecule CDMO Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Biomacromolecule CDMO as of 2024)
Table 19. Ranking of Global Top Biomacromolecule CDMO Companies by Revenue (US$ Million) in 2024
Table 20. Global 5 Largest Players Market Share by Biomacromolecule CDMO Revenue (CR5 and HHI) & (2020-2025)
Table 21. Global Key Players of Biomacromolecule CDMO, Headquarters and Area Served
Table 22. Global Key Players of Biomacromolecule CDMO, Product and Application
Table 23. Global Key Players of Biomacromolecule CDMO, Date of Enter into This Industry
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Biomacromolecule CDMO Market Size by Type (2020-2025) & (US$ Million)
Table 26. Global Biomacromolecule CDMO Revenue Market Share by Type (2020-2025)
Table 27. Global Biomacromolecule CDMO Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 28. Global Biomacromolecule CDMO Revenue Market Share by Type (2026-2031)
Table 29. Global Biomacromolecule CDMO Market Size by Application (2020-2025) & (US$ Million)
Table 30. Global Biomacromolecule CDMO Revenue Market Share by Application (2020-2025)
Table 31. Global Biomacromolecule CDMO Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 32. Global Biomacromolecule CDMO Revenue Market Share by Application (2026-2031)
Table 33. North America Biomacromolecule CDMO Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 34. North America Biomacromolecule CDMO Market Size by Country (2020-2025) & (US$ Million)
Table 35. North America Biomacromolecule CDMO Market Size by Country (2026-2031) & (US$ Million)
Table 36. Europe Biomacromolecule CDMO Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 37. Europe Biomacromolecule CDMO Market Size by Country (2020-2025) & (US$ Million)
Table 38. Europe Biomacromolecule CDMO Market Size by Country (2026-2031) & (US$ Million)
Table 39. Asia-Pacific Biomacromolecule CDMO Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 40. Asia-Pacific Biomacromolecule CDMO Market Size by Region (2020-2025) & (US$ Million)
Table 41. Asia-Pacific Biomacromolecule CDMO Market Size by Region (2026-2031) & (US$ Million)
Table 42. Latin America Biomacromolecule CDMO Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 43. Latin America Biomacromolecule CDMO Market Size by Country (2020-2025) & (US$ Million)
Table 44. Latin America Biomacromolecule CDMO Market Size by Country (2026-2031) & (US$ Million)
Table 45. Middle East & Africa Biomacromolecule CDMO Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 46. Middle East & Africa Biomacromolecule CDMO Market Size by Country (2020-2025) & (US$ Million)
Table 47. Middle East & Africa Biomacromolecule CDMO Market Size by Country (2026-2031) & (US$ Million)
Table 48. Lonza Company Details
Table 49. Lonza Business Overview
Table 50. Lonza Biomacromolecule CDMO Product
Table 51. Lonza Revenue in Biomacromolecule CDMO Business (2020-2025) & (US$ Million)
Table 52. Lonza Recent Development
Table 53. Wuxi Biologics (Cayman) Inc. Company Details
Table 54. Wuxi Biologics (Cayman) Inc. Business Overview
Table 55. Wuxi Biologics (Cayman) Inc. Biomacromolecule CDMO Product
Table 56. Wuxi Biologics (Cayman) Inc. Revenue in Biomacromolecule CDMO Business (2020-2025) & (US$ Million)
Table 57. Wuxi Biologics (Cayman) Inc. Recent Development
Table 58. Catalent Company Details
Table 59. Catalent Business Overview
Table 60. Catalent Biomacromolecule CDMO Product
Table 61. Catalent Revenue in Biomacromolecule CDMO Business (2020-2025) & (US$ Million)
Table 62. Catalent Recent Development
Table 63. Thermo Fisher Scientific Company Details
Table 64. Thermo Fisher Scientific Business Overview
Table 65. Thermo Fisher Scientific Biomacromolecule CDMO Product
Table 66. Thermo Fisher Scientific Revenue in Biomacromolecule CDMO Business (2020-2025) & (US$ Million)
Table 67. Thermo Fisher Scientific Recent Development
Table 68. Samsung Biologics Company Details
Table 69. Samsung Biologics Business Overview
Table 70. Samsung Biologics Biomacromolecule CDMO Product
Table 71. Samsung Biologics Revenue in Biomacromolecule CDMO Business (2020-2025) & (US$ Million)
Table 72. Samsung Biologics Recent Development
Table 73. Rentschler Biopharma Company Details
Table 74. Rentschler Biopharma Business Overview
Table 75. Rentschler Biopharma Biomacromolecule CDMO Product
Table 76. Rentschler Biopharma Revenue in Biomacromolecule CDMO Business (2020-2025) & (US$ Million)
Table 77. Rentschler Biopharma Recent Development
Table 78. Baxter Biopharma Solutions Company Details
Table 79. Baxter Biopharma Solutions Business Overview
Table 80. Baxter Biopharma Solutions Biomacromolecule CDMO Product
Table 81. Baxter Biopharma Solutions Revenue in Biomacromolecule CDMO Business (2020-2025) & (US$ Million)
Table 82. Baxter Biopharma Solutions Recent Development
Table 83. Merck BioReliance Company Details
Table 84. Merck BioReliance Business Overview
Table 85. Merck BioReliance Biomacromolecule CDMO Product
Table 86. Merck BioReliance Revenue in Biomacromolecule CDMO Business (2020-2025) & (US$ Million)
Table 87. Merck BioReliance Recent Development
Table 88. Cytovance Biologics Company Details
Table 89. Cytovance Biologics Business Overview
Table 90. Cytovance Biologics Biomacromolecule CDMO Product
Table 91. Cytovance Biologics Revenue in Biomacromolecule CDMO Business (2020-2025) & (US$ Million)
Table 92. Cytovance Biologics Recent Development
Table 93. AGC Biologics Company Details
Table 94. AGC Biologics Business Overview
Table 95. AGC Biologics Biomacromolecule CDMO Product
Table 96. AGC Biologics Revenue in Biomacromolecule CDMO Business (2020-2025) & (US$ Million)
Table 97. AGC Biologics Recent Development
Table 98. Abzena Company Details
Table 99. Abzena Business Overview
Table 100. Abzena Biomacromolecule CDMO Product
Table 101. Abzena Revenue in Biomacromolecule CDMO Business (2020-2025) & (US$ Million)
Table 102. Abzena Recent Development
Table 103. Emergent BioSolutions Company Details
Table 104. Emergent BioSolutions Business Overview
Table 105. Emergent BioSolutions Biomacromolecule CDMO Product
Table 106. Emergent BioSolutions Revenue in Biomacromolecule CDMO Business (2020-2025) & (US$ Million)
Table 107. Emergent BioSolutions Recent Development
Table 108. ProBioGen Company Details
Table 109. ProBioGen Business Overview
Table 110. ProBioGen Biomacromolecule CDMO Product
Table 111. ProBioGen Revenue in Biomacromolecule CDMO Business (2020-2025) & (US$ Million)
Table 112. ProBioGen Recent Development
Table 113. Goodwin Biotechnology Company Details
Table 114. Goodwin Biotechnology Business Overview
Table 115. Goodwin Biotechnology Biomacromolecule CDMO Product
Table 116. Goodwin Biotechnology Revenue in Biomacromolecule CDMO Business (2020-2025) & (US$ Million)
Table 117. Goodwin Biotechnology Recent Development
Table 118. KBI Biopharma Company Details
Table 119. KBI Biopharma Business Overview
Table 120. KBI Biopharma Biomacromolecule CDMO Product
Table 121. KBI Biopharma Revenue in Biomacromolecule CDMO Business (2020-2025) & (US$ Million)
Table 122. KBI Biopharma Recent Development
Table 123. Asymchem Laboratories (Tianjin) Co., Ltd. Company Details
Table 124. Asymchem Laboratories (Tianjin) Co., Ltd. Business Overview
Table 125. Asymchem Laboratories (Tianjin) Co., Ltd. Biomacromolecule CDMO Product
Table 126. Asymchem Laboratories (Tianjin) Co., Ltd. Revenue in Biomacromolecule CDMO Business (2020-2025) & (US$ Million)
Table 127. Asymchem Laboratories (Tianjin) Co., Ltd. Recent Development
Table 128. Shanghai Chempartner Lifescience Co., Ltd. Company Details
Table 129. Shanghai Chempartner Lifescience Co., Ltd. Business Overview
Table 130. Shanghai Chempartner Lifescience Co., Ltd. Biomacromolecule CDMO Product
Table 131. Shanghai Chempartner Lifescience Co., Ltd. Revenue in Biomacromolecule CDMO Business (2020-2025) & (US$ Million)
Table 132. Shanghai Chempartner Lifescience Co., Ltd. Recent Development
Table 133. Zhejiang Jian Xin Yuan Li Pharmaceuticals Co., Ltd. Company Details
Table 134. Zhejiang Jian Xin Yuan Li Pharmaceuticals Co., Ltd. Business Overview
Table 135. Zhejiang Jian Xin Yuan Li Pharmaceuticals Co., Ltd. Biomacromolecule CDMO Product
Table 136. Zhejiang Jian Xin Yuan Li Pharmaceuticals Co., Ltd. Revenue in Biomacromolecule CDMO Business (2020-2025) & (US$ Million)
Table 137. Zhejiang Jian Xin Yuan Li Pharmaceuticals Co., Ltd. Recent Development
Table 138. Genscript Biotech Company Details
Table 139. Genscript Biotech Business Overview
Table 140. Genscript Biotech Biomacromolecule CDMO Product
Table 141. Genscript Biotech Revenue in Biomacromolecule CDMO Business (2020-2025) & (US$ Million)
Table 142. Genscript Biotech Recent Development
Table 143. Beijing Joinn Biologics Co., Ltd. Company Details
Table 144. Beijing Joinn Biologics Co., Ltd. Business Overview
Table 145. Beijing Joinn Biologics Co., Ltd. Biomacromolecule CDMO Product
Table 146. Beijing Joinn Biologics Co., Ltd. Revenue in Biomacromolecule CDMO Business (2020-2025) & (US$ Million)
Table 147. Beijing Joinn Biologics Co., Ltd. Recent Development
Table 148. Research Programs/Design for This Report
Table 149. Key Data Information from Secondary Sources
Table 150. Key Data Information from Primary Sources
Table 151. Authors List of This Report
List of Figures
Figure 1. Biomacromolecule CDMO Picture
Figure 2. Global Biomacromolecule CDMO Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Biomacromolecule CDMO Market Share by Type: 2024 VS 2031
Figure 4. Biologics CDMO Features
Figure 5. Viral Vaccine Production CDMO Features
Figure 6. Analyze and Test CDMOs Features
Figure 7. Others Features
Figure 8. Global Biomacromolecule CDMO Market Size by Application (2020-2031) & (US$ Million)
Figure 9. Global Biomacromolecule CDMO Market Share by Application: 2024 VS 2031
Figure 10. Drug Development Case Studies
Figure 11. Vaccine Production Case Studies
Figure 12. Technology Transfer Case Studies
Figure 13. Others Case Studies
Figure 14. Biomacromolecule CDMO Report Years Considered
Figure 15. Global Biomacromolecule CDMO Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 16. Global Biomacromolecule CDMO Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 17. Global Biomacromolecule CDMO Market Share by Region: 2024 VS 2031
Figure 18. Global Biomacromolecule CDMO Market Share by Players in 2024
Figure 19. Global Top Biomacromolecule CDMO Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Biomacromolecule CDMO as of 2024)
Figure 20. The Top 10 and 5 Players Market Share by Biomacromolecule CDMO Revenue in 2024
Figure 21. North America Biomacromolecule CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 22. North America Biomacromolecule CDMO Market Share by Country (2020-2031)
Figure 23. United States Biomacromolecule CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 24. Canada Biomacromolecule CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 25. Europe Biomacromolecule CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 26. Europe Biomacromolecule CDMO Market Share by Country (2020-2031)
Figure 27. Germany Biomacromolecule CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. France Biomacromolecule CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. U.K. Biomacromolecule CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Italy Biomacromolecule CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Russia Biomacromolecule CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. Nordic Countries Biomacromolecule CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. Asia-Pacific Biomacromolecule CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. Asia-Pacific Biomacromolecule CDMO Market Share by Region (2020-2031)
Figure 35. China Biomacromolecule CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. Japan Biomacromolecule CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. South Korea Biomacromolecule CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. Southeast Asia Biomacromolecule CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. India Biomacromolecule CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. Australia Biomacromolecule CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. Latin America Biomacromolecule CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Latin America Biomacromolecule CDMO Market Share by Country (2020-2031)
Figure 43. Mexico Biomacromolecule CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 44. Brazil Biomacromolecule CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. Middle East & Africa Biomacromolecule CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. Middle East & Africa Biomacromolecule CDMO Market Share by Country (2020-2031)
Figure 47. Turkey Biomacromolecule CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 48. Saudi Arabia Biomacromolecule CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 49. UAE Biomacromolecule CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 50. Lonza Revenue Growth Rate in Biomacromolecule CDMO Business (2020-2025)
Figure 51. Wuxi Biologics (Cayman) Inc. Revenue Growth Rate in Biomacromolecule CDMO Business (2020-2025)
Figure 52. Catalent Revenue Growth Rate in Biomacromolecule CDMO Business (2020-2025)
Figure 53. Thermo Fisher Scientific Revenue Growth Rate in Biomacromolecule CDMO Business (2020-2025)
Figure 54. Samsung Biologics Revenue Growth Rate in Biomacromolecule CDMO Business (2020-2025)
Figure 55. Rentschler Biopharma Revenue Growth Rate in Biomacromolecule CDMO Business (2020-2025)
Figure 56. Baxter Biopharma Solutions Revenue Growth Rate in Biomacromolecule CDMO Business (2020-2025)
Figure 57. Merck BioReliance Revenue Growth Rate in Biomacromolecule CDMO Business (2020-2025)
Figure 58. Cytovance Biologics Revenue Growth Rate in Biomacromolecule CDMO Business (2020-2025)
Figure 59. AGC Biologics Revenue Growth Rate in Biomacromolecule CDMO Business (2020-2025)
Figure 60. Abzena Revenue Growth Rate in Biomacromolecule CDMO Business (2020-2025)
Figure 61. Emergent BioSolutions Revenue Growth Rate in Biomacromolecule CDMO Business (2020-2025)
Figure 62. ProBioGen Revenue Growth Rate in Biomacromolecule CDMO Business (2020-2025)
Figure 63. Goodwin Biotechnology Revenue Growth Rate in Biomacromolecule CDMO Business (2020-2025)
Figure 64. KBI Biopharma Revenue Growth Rate in Biomacromolecule CDMO Business (2020-2025)
Figure 65. Asymchem Laboratories (Tianjin) Co., Ltd. Revenue Growth Rate in Biomacromolecule CDMO Business (2020-2025)
Figure 66. Shanghai Chempartner Lifescience Co., Ltd. Revenue Growth Rate in Biomacromolecule CDMO Business (2020-2025)
Figure 67. Zhejiang Jian Xin Yuan Li Pharmaceuticals Co., Ltd. Revenue Growth Rate in Biomacromolecule CDMO Business (2020-2025)
Figure 68. Genscript Biotech Revenue Growth Rate in Biomacromolecule CDMO Business (2020-2025)
Figure 69. Beijing Joinn Biologics Co., Ltd. Revenue Growth Rate in Biomacromolecule CDMO Business (2020-2025)
Figure 70. Bottom-up and Top-down Approaches for This Report
Figure 71. Data Triangulation
Figure 72. Key Executives Interviewed
Table 1. Global Biomacromolecule CDMO Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Biologics CDMO
Table 3. Key Players of Viral Vaccine Production CDMO
Table 4. Key Players of Analyze and Test CDMOs
Table 5. Key Players of Others
Table 6. Global Biomacromolecule CDMO Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 7. Global Biomacromolecule CDMO Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 8. Global Biomacromolecule CDMO Market Size by Region (2020-2025) & (US$ Million)
Table 9. Global Biomacromolecule CDMO Market Share by Region (2020-2025)
Table 10. Global Biomacromolecule CDMO Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 11. Global Biomacromolecule CDMO Market Share by Region (2026-2031)
Table 12. Biomacromolecule CDMO Market Trends
Table 13. Biomacromolecule CDMO Market Drivers
Table 14. Biomacromolecule CDMO Market Challenges
Table 15. Biomacromolecule CDMO Market Restraints
Table 16. Global Biomacromolecule CDMO Revenue by Players (2020-2025) & (US$ Million)
Table 17. Global Biomacromolecule CDMO Market Share by Players (2020-2025)
Table 18. Global Top Biomacromolecule CDMO Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Biomacromolecule CDMO as of 2024)
Table 19. Ranking of Global Top Biomacromolecule CDMO Companies by Revenue (US$ Million) in 2024
Table 20. Global 5 Largest Players Market Share by Biomacromolecule CDMO Revenue (CR5 and HHI) & (2020-2025)
Table 21. Global Key Players of Biomacromolecule CDMO, Headquarters and Area Served
Table 22. Global Key Players of Biomacromolecule CDMO, Product and Application
Table 23. Global Key Players of Biomacromolecule CDMO, Date of Enter into This Industry
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Biomacromolecule CDMO Market Size by Type (2020-2025) & (US$ Million)
Table 26. Global Biomacromolecule CDMO Revenue Market Share by Type (2020-2025)
Table 27. Global Biomacromolecule CDMO Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 28. Global Biomacromolecule CDMO Revenue Market Share by Type (2026-2031)
Table 29. Global Biomacromolecule CDMO Market Size by Application (2020-2025) & (US$ Million)
Table 30. Global Biomacromolecule CDMO Revenue Market Share by Application (2020-2025)
Table 31. Global Biomacromolecule CDMO Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 32. Global Biomacromolecule CDMO Revenue Market Share by Application (2026-2031)
Table 33. North America Biomacromolecule CDMO Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 34. North America Biomacromolecule CDMO Market Size by Country (2020-2025) & (US$ Million)
Table 35. North America Biomacromolecule CDMO Market Size by Country (2026-2031) & (US$ Million)
Table 36. Europe Biomacromolecule CDMO Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 37. Europe Biomacromolecule CDMO Market Size by Country (2020-2025) & (US$ Million)
Table 38. Europe Biomacromolecule CDMO Market Size by Country (2026-2031) & (US$ Million)
Table 39. Asia-Pacific Biomacromolecule CDMO Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 40. Asia-Pacific Biomacromolecule CDMO Market Size by Region (2020-2025) & (US$ Million)
Table 41. Asia-Pacific Biomacromolecule CDMO Market Size by Region (2026-2031) & (US$ Million)
Table 42. Latin America Biomacromolecule CDMO Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 43. Latin America Biomacromolecule CDMO Market Size by Country (2020-2025) & (US$ Million)
Table 44. Latin America Biomacromolecule CDMO Market Size by Country (2026-2031) & (US$ Million)
Table 45. Middle East & Africa Biomacromolecule CDMO Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 46. Middle East & Africa Biomacromolecule CDMO Market Size by Country (2020-2025) & (US$ Million)
Table 47. Middle East & Africa Biomacromolecule CDMO Market Size by Country (2026-2031) & (US$ Million)
Table 48. Lonza Company Details
Table 49. Lonza Business Overview
Table 50. Lonza Biomacromolecule CDMO Product
Table 51. Lonza Revenue in Biomacromolecule CDMO Business (2020-2025) & (US$ Million)
Table 52. Lonza Recent Development
Table 53. Wuxi Biologics (Cayman) Inc. Company Details
Table 54. Wuxi Biologics (Cayman) Inc. Business Overview
Table 55. Wuxi Biologics (Cayman) Inc. Biomacromolecule CDMO Product
Table 56. Wuxi Biologics (Cayman) Inc. Revenue in Biomacromolecule CDMO Business (2020-2025) & (US$ Million)
Table 57. Wuxi Biologics (Cayman) Inc. Recent Development
Table 58. Catalent Company Details
Table 59. Catalent Business Overview
Table 60. Catalent Biomacromolecule CDMO Product
Table 61. Catalent Revenue in Biomacromolecule CDMO Business (2020-2025) & (US$ Million)
Table 62. Catalent Recent Development
Table 63. Thermo Fisher Scientific Company Details
Table 64. Thermo Fisher Scientific Business Overview
Table 65. Thermo Fisher Scientific Biomacromolecule CDMO Product
Table 66. Thermo Fisher Scientific Revenue in Biomacromolecule CDMO Business (2020-2025) & (US$ Million)
Table 67. Thermo Fisher Scientific Recent Development
Table 68. Samsung Biologics Company Details
Table 69. Samsung Biologics Business Overview
Table 70. Samsung Biologics Biomacromolecule CDMO Product
Table 71. Samsung Biologics Revenue in Biomacromolecule CDMO Business (2020-2025) & (US$ Million)
Table 72. Samsung Biologics Recent Development
Table 73. Rentschler Biopharma Company Details
Table 74. Rentschler Biopharma Business Overview
Table 75. Rentschler Biopharma Biomacromolecule CDMO Product
Table 76. Rentschler Biopharma Revenue in Biomacromolecule CDMO Business (2020-2025) & (US$ Million)
Table 77. Rentschler Biopharma Recent Development
Table 78. Baxter Biopharma Solutions Company Details
Table 79. Baxter Biopharma Solutions Business Overview
Table 80. Baxter Biopharma Solutions Biomacromolecule CDMO Product
Table 81. Baxter Biopharma Solutions Revenue in Biomacromolecule CDMO Business (2020-2025) & (US$ Million)
Table 82. Baxter Biopharma Solutions Recent Development
Table 83. Merck BioReliance Company Details
Table 84. Merck BioReliance Business Overview
Table 85. Merck BioReliance Biomacromolecule CDMO Product
Table 86. Merck BioReliance Revenue in Biomacromolecule CDMO Business (2020-2025) & (US$ Million)
Table 87. Merck BioReliance Recent Development
Table 88. Cytovance Biologics Company Details
Table 89. Cytovance Biologics Business Overview
Table 90. Cytovance Biologics Biomacromolecule CDMO Product
Table 91. Cytovance Biologics Revenue in Biomacromolecule CDMO Business (2020-2025) & (US$ Million)
Table 92. Cytovance Biologics Recent Development
Table 93. AGC Biologics Company Details
Table 94. AGC Biologics Business Overview
Table 95. AGC Biologics Biomacromolecule CDMO Product
Table 96. AGC Biologics Revenue in Biomacromolecule CDMO Business (2020-2025) & (US$ Million)
Table 97. AGC Biologics Recent Development
Table 98. Abzena Company Details
Table 99. Abzena Business Overview
Table 100. Abzena Biomacromolecule CDMO Product
Table 101. Abzena Revenue in Biomacromolecule CDMO Business (2020-2025) & (US$ Million)
Table 102. Abzena Recent Development
Table 103. Emergent BioSolutions Company Details
Table 104. Emergent BioSolutions Business Overview
Table 105. Emergent BioSolutions Biomacromolecule CDMO Product
Table 106. Emergent BioSolutions Revenue in Biomacromolecule CDMO Business (2020-2025) & (US$ Million)
Table 107. Emergent BioSolutions Recent Development
Table 108. ProBioGen Company Details
Table 109. ProBioGen Business Overview
Table 110. ProBioGen Biomacromolecule CDMO Product
Table 111. ProBioGen Revenue in Biomacromolecule CDMO Business (2020-2025) & (US$ Million)
Table 112. ProBioGen Recent Development
Table 113. Goodwin Biotechnology Company Details
Table 114. Goodwin Biotechnology Business Overview
Table 115. Goodwin Biotechnology Biomacromolecule CDMO Product
Table 116. Goodwin Biotechnology Revenue in Biomacromolecule CDMO Business (2020-2025) & (US$ Million)
Table 117. Goodwin Biotechnology Recent Development
Table 118. KBI Biopharma Company Details
Table 119. KBI Biopharma Business Overview
Table 120. KBI Biopharma Biomacromolecule CDMO Product
Table 121. KBI Biopharma Revenue in Biomacromolecule CDMO Business (2020-2025) & (US$ Million)
Table 122. KBI Biopharma Recent Development
Table 123. Asymchem Laboratories (Tianjin) Co., Ltd. Company Details
Table 124. Asymchem Laboratories (Tianjin) Co., Ltd. Business Overview
Table 125. Asymchem Laboratories (Tianjin) Co., Ltd. Biomacromolecule CDMO Product
Table 126. Asymchem Laboratories (Tianjin) Co., Ltd. Revenue in Biomacromolecule CDMO Business (2020-2025) & (US$ Million)
Table 127. Asymchem Laboratories (Tianjin) Co., Ltd. Recent Development
Table 128. Shanghai Chempartner Lifescience Co., Ltd. Company Details
Table 129. Shanghai Chempartner Lifescience Co., Ltd. Business Overview
Table 130. Shanghai Chempartner Lifescience Co., Ltd. Biomacromolecule CDMO Product
Table 131. Shanghai Chempartner Lifescience Co., Ltd. Revenue in Biomacromolecule CDMO Business (2020-2025) & (US$ Million)
Table 132. Shanghai Chempartner Lifescience Co., Ltd. Recent Development
Table 133. Zhejiang Jian Xin Yuan Li Pharmaceuticals Co., Ltd. Company Details
Table 134. Zhejiang Jian Xin Yuan Li Pharmaceuticals Co., Ltd. Business Overview
Table 135. Zhejiang Jian Xin Yuan Li Pharmaceuticals Co., Ltd. Biomacromolecule CDMO Product
Table 136. Zhejiang Jian Xin Yuan Li Pharmaceuticals Co., Ltd. Revenue in Biomacromolecule CDMO Business (2020-2025) & (US$ Million)
Table 137. Zhejiang Jian Xin Yuan Li Pharmaceuticals Co., Ltd. Recent Development
Table 138. Genscript Biotech Company Details
Table 139. Genscript Biotech Business Overview
Table 140. Genscript Biotech Biomacromolecule CDMO Product
Table 141. Genscript Biotech Revenue in Biomacromolecule CDMO Business (2020-2025) & (US$ Million)
Table 142. Genscript Biotech Recent Development
Table 143. Beijing Joinn Biologics Co., Ltd. Company Details
Table 144. Beijing Joinn Biologics Co., Ltd. Business Overview
Table 145. Beijing Joinn Biologics Co., Ltd. Biomacromolecule CDMO Product
Table 146. Beijing Joinn Biologics Co., Ltd. Revenue in Biomacromolecule CDMO Business (2020-2025) & (US$ Million)
Table 147. Beijing Joinn Biologics Co., Ltd. Recent Development
Table 148. Research Programs/Design for This Report
Table 149. Key Data Information from Secondary Sources
Table 150. Key Data Information from Primary Sources
Table 151. Authors List of This Report
List of Figures
Figure 1. Biomacromolecule CDMO Picture
Figure 2. Global Biomacromolecule CDMO Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Biomacromolecule CDMO Market Share by Type: 2024 VS 2031
Figure 4. Biologics CDMO Features
Figure 5. Viral Vaccine Production CDMO Features
Figure 6. Analyze and Test CDMOs Features
Figure 7. Others Features
Figure 8. Global Biomacromolecule CDMO Market Size by Application (2020-2031) & (US$ Million)
Figure 9. Global Biomacromolecule CDMO Market Share by Application: 2024 VS 2031
Figure 10. Drug Development Case Studies
Figure 11. Vaccine Production Case Studies
Figure 12. Technology Transfer Case Studies
Figure 13. Others Case Studies
Figure 14. Biomacromolecule CDMO Report Years Considered
Figure 15. Global Biomacromolecule CDMO Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 16. Global Biomacromolecule CDMO Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 17. Global Biomacromolecule CDMO Market Share by Region: 2024 VS 2031
Figure 18. Global Biomacromolecule CDMO Market Share by Players in 2024
Figure 19. Global Top Biomacromolecule CDMO Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Biomacromolecule CDMO as of 2024)
Figure 20. The Top 10 and 5 Players Market Share by Biomacromolecule CDMO Revenue in 2024
Figure 21. North America Biomacromolecule CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 22. North America Biomacromolecule CDMO Market Share by Country (2020-2031)
Figure 23. United States Biomacromolecule CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 24. Canada Biomacromolecule CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 25. Europe Biomacromolecule CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 26. Europe Biomacromolecule CDMO Market Share by Country (2020-2031)
Figure 27. Germany Biomacromolecule CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. France Biomacromolecule CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. U.K. Biomacromolecule CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Italy Biomacromolecule CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Russia Biomacromolecule CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. Nordic Countries Biomacromolecule CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. Asia-Pacific Biomacromolecule CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. Asia-Pacific Biomacromolecule CDMO Market Share by Region (2020-2031)
Figure 35. China Biomacromolecule CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. Japan Biomacromolecule CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. South Korea Biomacromolecule CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. Southeast Asia Biomacromolecule CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. India Biomacromolecule CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. Australia Biomacromolecule CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. Latin America Biomacromolecule CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Latin America Biomacromolecule CDMO Market Share by Country (2020-2031)
Figure 43. Mexico Biomacromolecule CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 44. Brazil Biomacromolecule CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. Middle East & Africa Biomacromolecule CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. Middle East & Africa Biomacromolecule CDMO Market Share by Country (2020-2031)
Figure 47. Turkey Biomacromolecule CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 48. Saudi Arabia Biomacromolecule CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 49. UAE Biomacromolecule CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 50. Lonza Revenue Growth Rate in Biomacromolecule CDMO Business (2020-2025)
Figure 51. Wuxi Biologics (Cayman) Inc. Revenue Growth Rate in Biomacromolecule CDMO Business (2020-2025)
Figure 52. Catalent Revenue Growth Rate in Biomacromolecule CDMO Business (2020-2025)
Figure 53. Thermo Fisher Scientific Revenue Growth Rate in Biomacromolecule CDMO Business (2020-2025)
Figure 54. Samsung Biologics Revenue Growth Rate in Biomacromolecule CDMO Business (2020-2025)
Figure 55. Rentschler Biopharma Revenue Growth Rate in Biomacromolecule CDMO Business (2020-2025)
Figure 56. Baxter Biopharma Solutions Revenue Growth Rate in Biomacromolecule CDMO Business (2020-2025)
Figure 57. Merck BioReliance Revenue Growth Rate in Biomacromolecule CDMO Business (2020-2025)
Figure 58. Cytovance Biologics Revenue Growth Rate in Biomacromolecule CDMO Business (2020-2025)
Figure 59. AGC Biologics Revenue Growth Rate in Biomacromolecule CDMO Business (2020-2025)
Figure 60. Abzena Revenue Growth Rate in Biomacromolecule CDMO Business (2020-2025)
Figure 61. Emergent BioSolutions Revenue Growth Rate in Biomacromolecule CDMO Business (2020-2025)
Figure 62. ProBioGen Revenue Growth Rate in Biomacromolecule CDMO Business (2020-2025)
Figure 63. Goodwin Biotechnology Revenue Growth Rate in Biomacromolecule CDMO Business (2020-2025)
Figure 64. KBI Biopharma Revenue Growth Rate in Biomacromolecule CDMO Business (2020-2025)
Figure 65. Asymchem Laboratories (Tianjin) Co., Ltd. Revenue Growth Rate in Biomacromolecule CDMO Business (2020-2025)
Figure 66. Shanghai Chempartner Lifescience Co., Ltd. Revenue Growth Rate in Biomacromolecule CDMO Business (2020-2025)
Figure 67. Zhejiang Jian Xin Yuan Li Pharmaceuticals Co., Ltd. Revenue Growth Rate in Biomacromolecule CDMO Business (2020-2025)
Figure 68. Genscript Biotech Revenue Growth Rate in Biomacromolecule CDMO Business (2020-2025)
Figure 69. Beijing Joinn Biologics Co., Ltd. Revenue Growth Rate in Biomacromolecule CDMO Business (2020-2025)
Figure 70. Bottom-up and Top-down Approaches for This Report
Figure 71. Data Triangulation
Figure 72. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Global Electrolytes for Lithium-Ion Batteries Market Research Report 2025
Jul 14, 25
Global Vanadium Products Market Research Report 2025
Jul 14, 25
Global High-purity Vanadium Oxide Market Research Report 2025
Jul 14, 25
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232